Dividend Aristocrats Part 25 of 52: CR Bard

What if someone could apply a buy-dispose-repeat process to the medical supply industry? Certainly, that would be a very profitable company. CR Bard (BCR) does just that.In fact, 90% of the company’s products are single use products.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.